Overall, insulin icodec represents an important advancement in diabetes care, with the potential to simplify insulin regimens and improve patient-centered outcomes, although further studies are warranted to evaluate long-term safety and broader clinical applications. The gene discussed is INS; the disease is diabetes mellitus.